(Q30311976)

16 June 2017

title

Comparative molecular field analysis and QSAR on substrates binding to cytochrome p450 2D6. (English)

1 reference

16 June 2017

Shahriar Haji-Momenian

1

0 references

author name string

Jayson M Rieger

2

1 reference

16 June 2017

Timothy L Macdonald

3

1 reference

16 June 2017

Milton L Brown

4

1 reference

16 June 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Bioorganic & Medicinal Chemistry

16 June 2017

published in

1 reference

16 June 2017

volume

11

1 reference

16 June 2017

issue

24

1 reference

16 June 2017

page(s)

5545-5554

1 reference

The metabolism of tamoxifen by human cytochromes P450 is rationalized by molecular modelling of the enzyme-substrate interactions: potential importance to its proposed anti-carcinogenic/carcinogenic actions

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

The catalytic mechanism of cytochrome P450 BM3 involves a 6 Å movement of the bound substrate on reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Redox cycling by cytochrome P-450

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

An improved and updated version of the compact procedure for the evaluation of P450-mediated chemical activation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

The P450 catalytic cycle and oxygenation mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Cytochrome P-450 oxidations and the generation of biologically reactive intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

1 reference

7 January 2021

Dose-response variation among different populations

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Cytochrome P450: genetic polymorphism and drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Structural and mechanistic studies of galactoside acetyltransferase, the Escherichia coli LacA gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Species differences in metabolism and pharmacokinetics: are we close to an understanding?

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin binding

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Enantioselectivity of bunitrolol 4-hydroxylation is reversed by the change of an amino acid residue from valine to methionine at position 374 of cytochrome P450-2D6.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Buried waters and internal cavities in monomeric proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

A predicted three-dimensional structure of human cytochrome P450: implications for substrate specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Improved Binding of Cytochrome P450cam Substrate Analogues Designed To Fill Extra Space in the Substrate Binding Pocket†

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Active-site topologies of human CYP2D6 and its aspartate-301 --> glutamate, asparagine, and glycine mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Structural determinants of cytochrome P450 substrate specificity, binding affinity and catalytic rate

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Extension of a predictive substrate model for human cytochrome P4502D6

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: structural studies on specific CYP2D6 substrate metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Molecular orbital-generated QSARs in a homologous series of alkoxyresorufins and studies of their interactive docking with P450s

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structure

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Modeling the active sites of cytochrome P450s and glutathione S-transferases, two of the most important biotransformation enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

A refined substrate model for human cytochrome P450 2D6

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

An ab initio approach to the understanding of cytochrome P450-ligand interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Ab initio molecular modeling in the study of drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Computational chemistry in biotransformational and toxicological research. Mechanisms of oxidation by and active site structure of cytochromes P-450

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Ab initio calculations on iron-porphyrin model systems for intermediates in the oxidative cycle of cytochrome P450s

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Active site analysis of P450 enzymes: comparative magnetic circular dichroism spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Active-site analysis of ferric P450 enzymes: hydrogen-bonding effects on the circular dichroism spectra

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Metabolism of carteolol by cDNA-expressed human cytochrome P450.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Kinetics of in vitro metabolism of methoxyphenamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Variable contribution of CYP2D6 to the N-dealkylation of S-(-)-propranolol by human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Venlafaxine oxidation in vitro is catalysed by CYP2D6.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Dopamine formation from tyramine by CYP2D6.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Preferential inhibition of CYP1A enzymes in hepatic microsomes by mexiletine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

In vitro assessment of various cytochromes P450 and glucuronosyltransferases using the antiarrhythmic propafenone as a probe drug

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Preparation and crystal structure of 6-acetyl-1-iodocodeine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Structure of nortriptyline hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

X-ray structure determination of (2S, 3R)-3-amino-2-hydroxy-4-phenylbutanoic acid, a new amino acid component of bestatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Validation of the general purpose Tripos 5.2 force field

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900525-X

7 January 2021

10.1016/S0968-0896(03)00525-X

Identifiers

DOI

1 reference

16 June 2017

1 reference